US FDA approves Amgen's biosimilar to AstraZeneca's rare blood disorder treatment

The U.S. Food and Drug Administration
approved on Tuesday Amgen's Bkemv, the first biosimilar
to AstraZeneca's rare blood disorder treatment Soliris.
Amgen's drug will be marketed under...

Related Keywords

Bengaluru , Karnataka , India , Amgen Bkemv , Alan Barona , Astrazeneca , Reuters , Alexion Pharmaceuticals , Amgen , Drug Administration , Tuesday Amgen ,